Pangea Bio
Developer of a novel medicines platform designed to treat neurological disorders. The company uses artificial intelligence to uncover promising molecules from nature's diverse chemical space, enhanced...
Valuation
$78.7M
Latest known
Share Price
N/A
Total Raised
$20.5M
Last Round
N/A